Medicare Enrolled
Dr. Yeshvant Navalgund, MD
Pain Medicine · Greensburg, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Navalgund from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Navalgund?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Navalgund
Dr. Yeshvant Navalgund is a pain medicine specialist in Greensburg, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Navalgund performed 10,281 Medicare services across 1,161 unique beneficiaries.
Between the years covered by Open Payments, Dr. Navalgund received a total of $527,369 from 48 pharmaceutical and/or device companies across 1041 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Navalgund is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 20% volume in PA
$527,369 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,281
Medicare services
Top 20% in PA for pain medicine
1,161
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~514 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Joint lubricant injection (Gel-Syn) An injection of hyaluronan or its derivative into a joint space to supplement joint fluid. |
8,736 | $0 | $10 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
242 | $111 | $558 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
118 | $107 | $567 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
103 | $61 | $332 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
89 | $76 | $320 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
84 | $26 | $210 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
77 | $92 | $390 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
70 | $73 | $375 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
69 | $43 | $180 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
68 | $126 | $580 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
66 | $102 | $430 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
65 | $94 | $450 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
61 | $229 | $1,414 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
60 | $70 | $367 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
49 | $79 | $379 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
40 | $88 | $370 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
36 | $35 | $150 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
33 | $27 | $138 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
33 | $107 | $527 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
32 | $59 | $190 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
31 | $195 | $600 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
29 | $78 | $340 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
27 | $60 | $296 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
17 | $65 | $306 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
17 | $199 | $1,147 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint. |
16 | $68 | $331 |
| Minimally invasive spine decompression, lower spine A minimally invasive procedure to remove bone from the lower spine to relieve pressure on nerve tissue, guided by imaging and accessed through the skin. |
13 | $807 | $3,500 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$527,369
Total received (2018-2024)
Avg $75,338/year across 7 years
Top 4% in PA for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
1,041
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$317,615 (60.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$170,769 (32.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$38,985 (7.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$36,431
2023
$64,896
2022
$109,151
2021
$46,017
2020
$28,830
2019
$91,027
2018
$151,017
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Averitas Pharma Inc.
$26,147
Abbott Laboratories
$8,339
BIOTRONIK NRO, Inc.
$463
Saluda Medical Americas, Inc.
$356
Nevro Corp.
$281
Vertos Medical, Inc.
$235
Boston Scientific Corporation
$137
MML US, Inc.
$116
Medtronic, Inc.
$100
Teva Pharmaceuticals USA, Inc.
$64
REVANCE THERAPEUTICS, INC.
$56
PFIZER INC.
$50
Fidia Pharma USA Inc.
$25
IBSA Pharma Inc.
$22
Collegium Pharmaceutical, Inc.
$20
PAINTEQ LLC
$20
Top 3 companies account for 95.9% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$157,142
Medtronic USA, Inc.
$75,838
Averitas Pharma Inc.
$72,074
GRT US Holding, Inc.
$65,518
SI-BONE, Inc.
$33,596
Nevro Corp.
$32,577
Medtronic, Inc.
$24,388
SI-BONE, INC.
$21,244
Jazz Pharmaceuticals Inc.
$15,751
TerSera Therapeutics LLC
$11,381
Zimmer Biomet Holdings, Inc.
$9,693
MML US, Inc.
$1,972
Nuvectra Corporation
$1,060
Vertos Medical, Inc.
$817
Boston Scientific Corporation
$551
BIOTRONIK NRO, Inc.
$543
Saluda Medical Americas, Inc.
$356
BOSTON SCIENTIFIC CORPORATION
$281
Pacira Pharmaceuticals Incorporated
$253
Almatica Pharma LLC
$248
Integra LifeSciences Corporation
$205
Stimwave Technologies Incorporated
$184
Teva Pharmaceuticals USA, Inc.
$148
Relievant Medsystems, Inc.
$139
ABBVIE INC.
$136
Stratus Medical, LLC
$126
PROTEGA PHARMACEUTIALS INC
$124
PFIZER INC.
$123
Curonix LLC
$108
Collegium Pharmaceutical, Inc.
$105
Novocure Inc.
$89
Amgen Inc.
$89
Spinal Simplicity, LLC
$64
REVANCE THERAPEUTICS, INC.
$56
Electronic Waveform Lab, Inc.
$46
IBSA Pharma Inc.
$44
BioDelivery Sciences International, Inc.
$43
Nalu Medical, Inc.
$35
RedHill Biopharma Inc.
$32
Vertiflex, Inc.
$27
Fidia Pharma USA Inc.
$25
Ferring Pharmaceuticals Inc.
$25
Allergan, Inc.
$22
Foundation Fusion Solutions, LLC
$21
Azurity Pharmaceuticals, Inc.
$20
PAINTEQ LLC
$20
Currax Pharmaceuticals LLC
$15
Amneal Pharmaceuticals LLC
$14
Top 3 companies account for 57.8% of all-time payments
Associated products mentioned in payments ›
ADAPTIVESTIM · AJOVY · AXIUM · Aimovig · Algovita · Arcos · Axium INS DRG IPG · Axium Sheath Braided DRG · BELBUCA · BIOTRONIK · BOTOX · Belbuca · CLOSUREFAST · CODMAN CERTAS · COMIRNATY · CONTRAVE · Cypher Mis Screw System · DAXI · DRG IPGs · EON C · ETERNA · EUFLEXXA · Eon Family of SCS IPGs · Evoke · Exparel · GENERAL PAIN MANAGEMENT · GRALISE · General - Pain Management · General - Vascular Access · HA MINUTEMAN G3-R · HYMOVIS · Horizant · IFUSE IMPLANT · IFUSE IMPLANT SYSTEM · INFINION · INTELLIS · INTELLIS ADAPTIVESTIM · Infinion 16 · Intracept · KYPHON Balloon Kyphoplasty · LICART · LYRICA · LYVISPAH · MYSTIM · Maxan Cervical System · Movantik · NURTEC ODT · Nalu Neurostimulation System · Neuromodulation Dspsbls and Accs · Nimbus · OCTRODE · OSS · Octrode SCS Leads · Omnia · Oncology · PAINTEQ · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · Penta SCS Leads · Persona · Prialt · Proclaim DRG IPG · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · Prospera · Protege Family of SCS IPGs · QULIPTA · QUTENZA · Qutenza · RESTORE · REYVOW · ROSA · ROXYBOND · ReActiv8 · SCS IPGs · SCS leads · SPECTRA WAVEWRITER · SWIFT-LOCK · SYNCHROMED · Senza · Senza Spinal Cord Stimulation System · SlimTip lead DRG Lead · StimQ Peripheral Nerve StimulatorSystem · StimQ Receiver Stimulator Kit Channel A US w/Receiver · Superion · Superion ISS · TARGETSTIM · Taperloc · Tirosint · TriCor · UBRELVY · V-LOC 180 · V-Loc · VANTA ADAPTIVESTIM · VECTRIS · WaveWriter Alpha Prime 16 · XTAMPZA · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (60%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pain medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for pain medicine in PA.
Geographic Context
Pain medicines within 10 mi
6
Per 100K population
1.7
County median income
$72,468
Nearest hospital
EXCELA HEALTH WESTMORELAND REGIONAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Navalgund is a mixed practice specialist, with above-average Medicare volume (top 20% in PA), with speaking/promotional industry engagement in the top 4% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Navalgund experienced with joint lubricant injection (gel-syn)?
Based on Medicare claims data, Dr. Navalgund performed 8,736 joint lubricant injection (gel-syn) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Navalgund receive payments from pharmaceutical companies?
Yes. Dr. Navalgund received a total of $527,369 from 48 companies across 1,041 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Navalgund's costs compare to other pain medicines in Greensburg?
Dr. Navalgund's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Navalgund) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Greensburg
Browse pain medicines in Greensburg ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in PA
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in PA
Which PA pain medicines receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc.
By company
Averitas Pharma Inc. Payments to Doctors
See all physicians who received payments from Averitas Pharma Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology